Cited by 229Liver Disease and TransplantationFrailty in Older AdultsLiver Disease Diagnosis and Treatment

Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study

Open access
Lai, Jennifer C., Rahimi, Robert S., Verna, Elizabeth C., Kappus, Matthew R., Dunn, Michael A., McAdams-DeMarco, Mara, Haugen, Christine E., Volk, Michael L. +6 more·2019·Gastroenterology

Abstract

Background & aims Frailty is associated with mortality in patients with cirrhosis. We measured frailty using 3 simple tests and calculated Liver Frailty Index (LFI) scores for patients at multiple ambulatory centers. We investigated associations between LFI scores, ascites, and hepatic encephalopathy (HE) and mortality. Methods Adults without hepatocellular carcinoma who were on the liver transplantation waitlist at 9 centers in the United States (N = 1044) were evaluated using the LFI; LFI scores of at least 4.5 indicated that patients were frail. We performed logistic regression analyses to assess associations between frailty and ascites or HE and competing risk regression analyses (with liver transplantation as the competing risk) to estimate sub-hazard ratios (sHRs) of waitlist mortality (death or removal from the waitlist). Results Of study subjects, 36% had ascites, 41% had HE, and 25% were frail. The odds of frailty were higher for patients with ascites (adjusted odd ratio 1.56, 95% confidence interval [CI] 1.15-2.14) or HE (odd ratio 2.45, 95% CI 1.80-3.33) than for those without these features. Larger proportions of frail patients with ascites (29%) or HE (30%) died while on the waitlist compared with patients who were not frail (17% of patients with ascites and 20% with HE). In univariable analysis, ascites (sHR 1.52, 95% CI 1.14-2.05), HE (sHR 1.84, 95% CI 1.38-2.45), and frailty (sHR 2.38, 95% CI 1.77-3.20) were associated with waitlist mortality. In adjusted models, only frailty remained significantly associated with waitlist mortality (sHR 1.82, 95% CI 1.31-2.52); ascites and HE were not. Conclusions Frailty is a prevalent complication of cirrhosis that is observed more frequently in patients with ascites or HE and independently associated with waitlist mortality. LFI scores can be used to objectively quantify risk of death related to frailty-in excess of liver disease severity-in patients with cirrhosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2019.01.028

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Malnutrition, frailty, and especially sarcopenia have become increasingly important in patients with advanced chronic liver disease.

    “Finally, malnutrition [105], frailty [106, 107] and especially sarcopenia [108, 109, 110, 111] have become increasingly important in patients with advanced chronic liver disease and should be evaluated and treated in each patient.”

    From Current treatment of non‐alcoholic fatty liver disease (2022) · cites this paper as [107]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 13

  1. [1]Kamath P A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2): 464– 470. doi: 10.1053/jhep.2001.22172. 11172350 · DOI
  2. [2]Kim WR, Biggins SW, Kremers WK, Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List. N Engl J Med. 2008; 359(10): 1018– 1026. doi: 10.1056/NEJMoa0801209. 18768945 PMC4374557 · DOI
  3. [3]Child CG, Turcotte JG. Surgery and portal hypertension In: Child CG, ed. The Liver and Portal Hypertension. Saunders; 1964: 50– 64.
  4. [4]Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty Predicts Waitlist Mortality in Liver Transplant Candidates. American journal of transplantation. 2014; 14(8): 1870– 1879. doi: 10.1111/ajt.12762. 24935609 PMC4107151 · DOI
  5. [5]Carey EJ, Steidley DE, Aqel BA, Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transplantation. 2010; 16(12): 1373– 1378. doi: 10.1002/lt.22167. 21117246 · DOI
  6. [6]Tandon P, Reddy KR, O’Leary JG, A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis. Hepatology. 2017; 65(1): 217– 224. doi: 10.1002/hep.28900. 27775842 · DOI
  7. [7]Tandon P, Tangri N, Thomas L, A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale. Am J Gastroenterol. 2016; 111(12): 1759– 1767. doi: 10.1038/ajg.2016.303. 27481305 · DOI
  8. [8]Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015; 62(2): 584– 590. doi: 10.1002/hep.27830. 25846824 PMC4768731 · DOI
  9. [9]Dunn MA, Josbeno DA, Tevar AD, Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization. Am J Gastroenterol. 2016; 111(12): 1768– 1775. doi: 10.1038/ajg.2016.336. 27575708 · DOI
  10. [12]Lai JC, Covinsky KE, McCulloch CE, Feng S. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis. Am J Gastroenterol. 2017; 10: 1– 8. doi: 10.1038/ajg.2017.443. PMC5866923 29231189 · DOI
  11. [14]Weissenborn K, Rückert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol. 1998; 28(4): 646– 653. 9566834
  12. [16]Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59(3): 255– 263. 15031310
  13. [17]Reuter B, Walter K, Bissonnette J, Assessment of the spectrum of hepatic encephalopathy: A multicenter study. Liver Transplantation. 2018; 24(5): 587– 594. doi: 10.1002/lt.25032. 29457869 PMC5912984 · DOI

Cited by

Authors
Lai, J. C., Rahimi, R. S., Verna, E. C., Kappus, M. R., Dunn, M. A., McAdams-DeMarco, M., Haugen, C. E., Volk, M. L., Duarte-Rojo, A., Ganger, D. R., O’Leary, J. G., Dodge, J. L., Ladner, D., & Segev, D. L.
Affiliations
  • University of California, San Francisco (US)
  • Baylor University Medical Center (US)
  • Columbia University Irving Medical Center (US)
  • Duke University (US)
  • University of Pittsburgh (US)
  • Johns Hopkins University (US)
  • Loma Linda University Medical Center (US)
  • Northwestern University (US)
  • Dallas VA Medical Center (US)
Corresponding author
Lai, Jennifer C.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2019-05
Volume
156
Issue
6
Pages
1675-1682
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2910818863
Cited by
229
References
4
Citations by year
2026: 27 · 2025: 30 · 2024: 25 · 2023: 30 · 2022: 32 · 2021: 39 · 2020: 34 · 2019: 12
FWCI
18.65
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institutes of Health (K23AG048337, R01AG059183, K24DK101828, F32AG053025, P30DK026743)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
Keywords
frailty, Liver Frailty Index, liver cirrhosis, liver transplant waiting list, waitlist mortality, ascites, hepatic encephalopathy, frailty assessment, mortality risk stratification, competing risk analysis, liver transplant candidates
MeSH terms
Frailty, Ascites, Female, Hepatic Encephalopathy, Humans, Liver Cirrhosis, Male, Middle Aged, Severity of Illness Index, United States, Waiting Lists, Liver Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review